Skip to main content
. 2022 Nov 14;13(6):e02742-22. doi: 10.1128/mbio.02742-22

TABLE 2.

Primers used in this study

ID Primer name Sequence (5′–3′) Restriction site Expected size
P019 pJNE05_part1.1a ACCTTCGGGAGCGCCTGA 3,106 bp
P020 pJNE05_part1.1b agtactattgaacgcgtGAATTCGGCTTATTCCCTAAC
P021 pJNE05_part2.1a ttagggaataagccgaattcacgcgttcaatagtactAAGCTTCCGATCCCCAATTCC 3,486 bp
P022 pJNE05_part2.1b cttcaggcgctcccgaaggtCTCGGGCCGTCTCTTGGG
P032 cdrA.1a cactaagtactCATTGTCGGTTTTTTGACGG
P033 cdrA.1b cactaacgcgtCGCACGTCAGTTTTCCAGCA
P010 ptac-dTomato.1a TTATAggcgcgcctgcaggtcgtaaatcactgc AscI site 419 bp plus dTomato ~1 kb
P011 ptac-dTomato.1b TATTAgcggccgccttctctcatccgccaaaac NotI site
P014 T0T1-terminators.1a atgagagaagggcgcgccAGCTTAATTAGCTGAGCTTGG AscI site mid-primer 300 bp
P015 T0T1-terminators.1b cctattctctagaactagtgCGGCGGATTTGTCCTACTC
P027 ebfp2.1a cactaggatccAATGGTGAGCAAGGGCGAGG BamHI site 746 bp
P029 ebfp2.2b CACATAAGCTTCTTACTTGTACAGCTCGTCCATGCC HindIII site
P012 pMG035-gibson.1a taccgggccccccctcgaggtcgacTGCAGGTCGTAAATCACTG SalI site mid-primer 1,075 bp
P013 pMG035-gibson.1b ttaagctggcgcgccCTTCTCTCATCCGCCAAAAC AscI site mid-primer